PHARMACOLOGY 9T`
rh
, TestrhBankrh-rhPharmacology:rhArhPatient-
CenteredrhNursingrhProcessrhApproachrh(9thrhEdition,rh2017)
PHARMACOLOGYrh9THrhEDITIONrhMCCUISTIONrhTESTrhBANK
TablerhofrhContents
TablerhofrhContents Chapterrh28:rhPeptides,rh
Antimalarial,rhand
Chapterrh01:rhDrugrhDevelopmentrhandr Anthelmintic
hEthicalrhConsiderations Chapterrh29:rhHIV-rhandrhAIDS-
Chapterrh02:rhPharmacokinetics,rh RelatedrhDrugs
Pharmacodynamics,rhandrhPharma Chapterrh30:rhTransplantrhDrugs
cogenetics rhChapterrh31:rhVaccinesrhChapt
Chapterrh03:rhCulturalrhConsiderationsrh errh32:rhAnticancerrhDrugs
Chapterrh04:rhComplementaryrhandrhAlt Chapterrh33:rhTargetedrhTherapiesrhtorhTreat
ernativerhTherapies rhCancer
Chapterrh05:rhPediatricrhConsiderationsrh Chapterrh34:rhBiologicrhResponser
Chapterrh06:rhGeriatricrhConsiderationsrh hModifiers
Chapterrh07:rhDrugsrhinrhSubstancerhUser Chapterrh35:rhUpperrhRespiratoryr
hDisorder hDisorders
Chapterrh08:rhTherhNursingrhProcessrhandr Chapterrh36:rhLowerrhRespiratory
hPatient-CenteredrhCare rhDisorders
Chapterrh09:rhSafetyrhandrhQualityrh Chapterrh37:rhCardiacrhGlycosides,rhA
Chapterrh10:rhDrugrhAdministrationr ntianginals,rhandrhAntidysrhythmicsrh
hChapterrh11:rhDrugrhCalculationsrh Chapterrh38:rhDiuretics
Chapterrh12:rhFluidrhVolumerhandrh Chapterrh39:rhAntihypertensive
Electrolytes Chapterrh40:rhAnticoagulants,rhAntiplat
Chapterrh13:rhVitaminrhandrhMineral elets,rhandrhThrombolyticsrhChapterrh41
rhReplacement :rhAntihyperlipidemicsrhandrhPeripheral
Chapterrh14:rhNutritionalrhSupportrhChapt rhVasodilators
errh15:rhAdrenergicrhAgonistsrhandrhAnta Chapterrh42:rhGastrointestinalrhTractr
gonists hDisorders
Chapterrh16:rhCholinergicrhAgonistsrhandr Chapterrh43:rhAntiulcerrhDrugsrhChapte
hAntagonists rrh44:rhEyerhandrhEarrhDisordersrhChapt
Chapterrh17:rhStimulants errh45:rhDermatologicrhDisordersrhCha
Chapterrh18:rhDepressantsrhChapt pterrh46:rhPituitary,rhThyroid,rhParathyr
errh19:rhAntiseizurerhDrugs oid,rhandrhAdrenalrhDisordersrhChapterr
Chapterrh20:rhDrugsrhforrhParkinsonismrhandr h47:rhAntidiabetics
hAlzheimer'srhDisease Chapterrh48:rhUrinaryrhDisordersrhChap
Chapterrh21:rhDrugsrhforrhNeuromuscularr terrh49:rhPregnancyrhandrhPretermrhLab
hDisordersrhandrhMusclerhSpasmsrhChapte or
rrh22:rhAntipsychoticsrhandrhAnxiolytics Chapterrh50:rhLabor,rhDelivery,rhan
Chapterrh23:rhAntidepressantsrhandrhMoodrh drhPostpartum
Stabilizers Chapterrh51:rhNeonatalrhandrhNewborn
Chapterrh24:rhAntiinflammatories rhChapterrh52:rhWomen'srhReproductiv
Chapterrh25:rhAnalgesics erhHealth
Chapterrh26:rhAntibacterials Chapterrh53:rhMen'srhReproductiverhHealthr
Chapterrh27:rhAntituberculars,rhAntifungals,rh hChapterrh54:rhSexuallyrhTransmittedrhInfe
andrhAntivirals ctions
Chapterrh55:rhAdultrhandrhPediatri
, TestrhBankrh-rhPharmacology:rhArhPatient-
CenteredrhNursingrhProcessrhApproachrh(9thrhEdition,rh2017)
PHARMACOLOGYrh9THrhEDITIONrhMCCUISTIONrhTESTrhBANK
crhEmergencyrhDrugs
, TestrhBankrh-rhPharmacology:rhArhPatient-
CenteredrhNursingrhProcessrhApproachrh(9thrhEdition,rh2017)
PHARMACOLOGYrh9THrhEDITIONrhMCCUISTIONrhTESTrhBANK
Chapterrh01:rhDrugrhDevelopmentrhandrhEthicalrhConsiderations
MULTIPLErhCHOICE
1. TherhnurserhisrhpreparingrhtorhadministerrharhschedulerhIIrhinjectablerhdrugrhandrhisrhdrawin
grhuprhhalfrhofrhtherhcontentsrhofrharhSingle-userhvial.rhWhichrhnursingrhactionrhisrhcorrect?
a. Askrhanotherrhnurserhtorhobserverhandrhcosignrhwastingrhtherhremainingrhdrugrhfromrhtherhvial.
b. Keeprhtherhremainingrhamountrhinrhtherhpatient’srhdrawerrhtorhgiverhatrhtherhnextrhdose.
c. Recordrhtherhamountrhunusedrhinrhtherhpatient’srhmedicationrhrecord.
d. Disposerhofrhtherhvialrhwithrhtherhremainingrhdrugrhintorharhlockedrhcolle
ctionrhbox.rhANS:rhA
SchedulerhIIrhdrugsrharerhcontrolledrhsubstances,rhandrhallrhmustrhberhaccountedrhfor.rhWhen
rhwastingrharhportionrhofrharhdrug,rhanotherrhnurserhshouldrhobserverhandrhcosignrhthatrharhdr
ugrhwasrhwasted.
DIF:rhCOGNITIVErhLEVEL:rhApplyingrh(Applicatio
n)rhTOP:rhNURSINGrhPROCESS:rhNursingrhInter
vention
MSC:rhNCLEX:rhPhysiologicalrhIntegrity:rhPharmacologicalrhandrhParenteralrhTherapies
2. Arhpatientrhisrhprescribedrharhmedicationrhandrhasksrhtherhnurserhifrhtherhdrugrhisrhavailabler
hinrharhgenericrhform.rhTherhnurserhunderstandsrhthatrharhgenericrhmedicationrhwillrhhaverharhn
amerhthat
a. isrharhregisteredrhtrademark.
b. isrhalwaysrhcapitalized.
c. describesrhtherhdrugsrhchemicalrhstructure.
d. isrhnon-
proprietary.rhANS:rh
D
Therhgenericrhnamerhisrhtherhofficial,rhnon-
proprietaryrhnamerhforrharhdrug.rhTherhbrandrhnamerhisrhtherhtrademarkrhnamerhandrhisrhalwaysrh
capitalized.rhTherhchemicalrhnamerhdescribesrhtherhchemicalrhstructurerhofrhtherhdrug.
DIF:rhCOGNITIVErhLEVEL:rhUnderstandingrh(Comprehensi
on)rhTOP:rhNURSINGrhPROCESS:rhN/A
MSC:rhNCLEX:rhPhysiologicalrhIntegrity:rhPharmacologicalrhandrhParenteralrhTherapies
3. Arhpatientrhreceivesrharhprescriptionrhonrhwhichrhtherhproviderrhhasrhnotedrhthatrharhgenericr
hmedicationrhmayrhberhgiven.Therhpatientrhasksrhtherhnurserhwhatrhthisrhmeans.rhWhatrhwillrht
herhnurserhtellrhtherhpatientrhaboutrhgenericrhdrugs?
a. Theyrhcontainrhtherhsamerhinertrhingredientsrhasrhbrand-namerhdrugs.
b. Theyrhhaverhchemicalrhstructuresrhthatrharerhidenticalrhtorhproprietaryrhdrugs.
c. Theyrhtendrhtorhberhlessrhexpensiverhthanrhbrand-namerhdrugs.
d. Theyrhundergorhextensiverhtestingrhbeforerhtheyrharerhmar
keted.rhANS:rhC
GenericrhdrugsrharerhapprovedrhbyrhtherhFDArhifrhtheyrharerhprovedrhtorhberhbioequivalentrhtorhth
erhbrand-
rhnamerhdrug.rhTheyrhtendrhtorhberhlessrhexpensiverhbecauserhmanufacturersrhofrhtheserhdrugsrh
dorhnotrhhaverhtorhdorhtherhextensiverhtestingrhrequiredrhofrhbrand-
namerhdrugsrhbeforerhmarketing.rhTheyrharerhnotrhidenticalrhtorhbrand-
namerhdrugsrhandrhoftenrhhaverhdifferentrhinertrhingredients.
rh
, TestrhBankrh-rhPharmacology:rhArhPatient-
CenteredrhNursingrhProcessrhApproachrh(9thrhEdition,rh2017)
PHARMACOLOGYrh9THrhEDITIONrhMCCUISTIONrhTESTrhBANK
TablerhofrhContents
TablerhofrhContents Chapterrh28:rhPeptides,rh
Antimalarial,rhand
Chapterrh01:rhDrugrhDevelopmentrhandr Anthelmintic
hEthicalrhConsiderations Chapterrh29:rhHIV-rhandrhAIDS-
Chapterrh02:rhPharmacokinetics,rh RelatedrhDrugs
Pharmacodynamics,rhandrhPharma Chapterrh30:rhTransplantrhDrugs
cogenetics rhChapterrh31:rhVaccinesrhChapt
Chapterrh03:rhCulturalrhConsiderationsrh errh32:rhAnticancerrhDrugs
Chapterrh04:rhComplementaryrhandrhAlt Chapterrh33:rhTargetedrhTherapiesrhtorhTreat
ernativerhTherapies rhCancer
Chapterrh05:rhPediatricrhConsiderationsrh Chapterrh34:rhBiologicrhResponser
Chapterrh06:rhGeriatricrhConsiderationsrh hModifiers
Chapterrh07:rhDrugsrhinrhSubstancerhUser Chapterrh35:rhUpperrhRespiratoryr
hDisorder hDisorders
Chapterrh08:rhTherhNursingrhProcessrhandr Chapterrh36:rhLowerrhRespiratory
hPatient-CenteredrhCare rhDisorders
Chapterrh09:rhSafetyrhandrhQualityrh Chapterrh37:rhCardiacrhGlycosides,rhA
Chapterrh10:rhDrugrhAdministrationr ntianginals,rhandrhAntidysrhythmicsrh
hChapterrh11:rhDrugrhCalculationsrh Chapterrh38:rhDiuretics
Chapterrh12:rhFluidrhVolumerhandrh Chapterrh39:rhAntihypertensive
Electrolytes Chapterrh40:rhAnticoagulants,rhAntiplat
Chapterrh13:rhVitaminrhandrhMineral elets,rhandrhThrombolyticsrhChapterrh41
rhReplacement :rhAntihyperlipidemicsrhandrhPeripheral
Chapterrh14:rhNutritionalrhSupportrhChapt rhVasodilators
errh15:rhAdrenergicrhAgonistsrhandrhAnta Chapterrh42:rhGastrointestinalrhTractr
gonists hDisorders
Chapterrh16:rhCholinergicrhAgonistsrhandr Chapterrh43:rhAntiulcerrhDrugsrhChapte
hAntagonists rrh44:rhEyerhandrhEarrhDisordersrhChapt
Chapterrh17:rhStimulants errh45:rhDermatologicrhDisordersrhCha
Chapterrh18:rhDepressantsrhChapt pterrh46:rhPituitary,rhThyroid,rhParathyr
errh19:rhAntiseizurerhDrugs oid,rhandrhAdrenalrhDisordersrhChapterr
Chapterrh20:rhDrugsrhforrhParkinsonismrhandr h47:rhAntidiabetics
hAlzheimer'srhDisease Chapterrh48:rhUrinaryrhDisordersrhChap
Chapterrh21:rhDrugsrhforrhNeuromuscularr terrh49:rhPregnancyrhandrhPretermrhLab
hDisordersrhandrhMusclerhSpasmsrhChapte or
rrh22:rhAntipsychoticsrhandrhAnxiolytics Chapterrh50:rhLabor,rhDelivery,rhan
Chapterrh23:rhAntidepressantsrhandrhMoodrh drhPostpartum
Stabilizers Chapterrh51:rhNeonatalrhandrhNewborn
Chapterrh24:rhAntiinflammatories rhChapterrh52:rhWomen'srhReproductiv
Chapterrh25:rhAnalgesics erhHealth
Chapterrh26:rhAntibacterials Chapterrh53:rhMen'srhReproductiverhHealthr
Chapterrh27:rhAntituberculars,rhAntifungals,rh hChapterrh54:rhSexuallyrhTransmittedrhInfe
andrhAntivirals ctions
Chapterrh55:rhAdultrhandrhPediatri
, TestrhBankrh-rhPharmacology:rhArhPatient-
CenteredrhNursingrhProcessrhApproachrh(9thrhEdition,rh2017)
PHARMACOLOGYrh9THrhEDITIONrhMCCUISTIONrhTESTrhBANK
crhEmergencyrhDrugs
, TestrhBankrh-rhPharmacology:rhArhPatient-
CenteredrhNursingrhProcessrhApproachrh(9thrhEdition,rh2017)
PHARMACOLOGYrh9THrhEDITIONrhMCCUISTIONrhTESTrhBANK
Chapterrh01:rhDrugrhDevelopmentrhandrhEthicalrhConsiderations
MULTIPLErhCHOICE
1. TherhnurserhisrhpreparingrhtorhadministerrharhschedulerhIIrhinjectablerhdrugrhandrhisrhdrawin
grhuprhhalfrhofrhtherhcontentsrhofrharhSingle-userhvial.rhWhichrhnursingrhactionrhisrhcorrect?
a. Askrhanotherrhnurserhtorhobserverhandrhcosignrhwastingrhtherhremainingrhdrugrhfromrhtherhvial.
b. Keeprhtherhremainingrhamountrhinrhtherhpatient’srhdrawerrhtorhgiverhatrhtherhnextrhdose.
c. Recordrhtherhamountrhunusedrhinrhtherhpatient’srhmedicationrhrecord.
d. Disposerhofrhtherhvialrhwithrhtherhremainingrhdrugrhintorharhlockedrhcolle
ctionrhbox.rhANS:rhA
SchedulerhIIrhdrugsrharerhcontrolledrhsubstances,rhandrhallrhmustrhberhaccountedrhfor.rhWhen
rhwastingrharhportionrhofrharhdrug,rhanotherrhnurserhshouldrhobserverhandrhcosignrhthatrharhdr
ugrhwasrhwasted.
DIF:rhCOGNITIVErhLEVEL:rhApplyingrh(Applicatio
n)rhTOP:rhNURSINGrhPROCESS:rhNursingrhInter
vention
MSC:rhNCLEX:rhPhysiologicalrhIntegrity:rhPharmacologicalrhandrhParenteralrhTherapies
2. Arhpatientrhisrhprescribedrharhmedicationrhandrhasksrhtherhnurserhifrhtherhdrugrhisrhavailabler
hinrharhgenericrhform.rhTherhnurserhunderstandsrhthatrharhgenericrhmedicationrhwillrhhaverharhn
amerhthat
a. isrharhregisteredrhtrademark.
b. isrhalwaysrhcapitalized.
c. describesrhtherhdrugsrhchemicalrhstructure.
d. isrhnon-
proprietary.rhANS:rh
D
Therhgenericrhnamerhisrhtherhofficial,rhnon-
proprietaryrhnamerhforrharhdrug.rhTherhbrandrhnamerhisrhtherhtrademarkrhnamerhandrhisrhalwaysrh
capitalized.rhTherhchemicalrhnamerhdescribesrhtherhchemicalrhstructurerhofrhtherhdrug.
DIF:rhCOGNITIVErhLEVEL:rhUnderstandingrh(Comprehensi
on)rhTOP:rhNURSINGrhPROCESS:rhN/A
MSC:rhNCLEX:rhPhysiologicalrhIntegrity:rhPharmacologicalrhandrhParenteralrhTherapies
3. Arhpatientrhreceivesrharhprescriptionrhonrhwhichrhtherhproviderrhhasrhnotedrhthatrharhgenericr
hmedicationrhmayrhberhgiven.Therhpatientrhasksrhtherhnurserhwhatrhthisrhmeans.rhWhatrhwillrht
herhnurserhtellrhtherhpatientrhaboutrhgenericrhdrugs?
a. Theyrhcontainrhtherhsamerhinertrhingredientsrhasrhbrand-namerhdrugs.
b. Theyrhhaverhchemicalrhstructuresrhthatrharerhidenticalrhtorhproprietaryrhdrugs.
c. Theyrhtendrhtorhberhlessrhexpensiverhthanrhbrand-namerhdrugs.
d. Theyrhundergorhextensiverhtestingrhbeforerhtheyrharerhmar
keted.rhANS:rhC
GenericrhdrugsrharerhapprovedrhbyrhtherhFDArhifrhtheyrharerhprovedrhtorhberhbioequivalentrhtorhth
erhbrand-
rhnamerhdrug.rhTheyrhtendrhtorhberhlessrhexpensiverhbecauserhmanufacturersrhofrhtheserhdrugsrh
dorhnotrhhaverhtorhdorhtherhextensiverhtestingrhrequiredrhofrhbrand-
namerhdrugsrhbeforerhmarketing.rhTheyrharerhnotrhidenticalrhtorhbrand-
namerhdrugsrhandrhoftenrhhaverhdifferentrhinertrhingredients.
